Alamifovir PM
CAS No. 2986319-14-4
Alamifovir PM( —— )
Catalog No. M36005 CAS No. 2986319-14-4
Alamifovir PM is an analogue of Alamifovir, an HBV-specific antiviral compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 126 | In Stock |
|
| 10MG | 192 | In Stock |
|
| 25MG | 314 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | 578 | In Stock |
|
| 200MG | 775 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlamifovir PM
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlamifovir PM is an analogue of Alamifovir, an HBV-specific antiviral compound.
-
DescriptionAlamifovir PM is an analogue of Alamifovir, an HBV-specific antiviral compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2986319-14-4
-
Formula Weight317.37
-
Molecular FormulaC14H15N5O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc(Sc2nc(N)nc3n(CCO)cnc23)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
4-Hydroxy-3-methoxym...
Vanillyl mandelic acid (VMA) is a chemical intermediate in the synthesis of artificial vanilla flavorings and is an end-stage metabolite of the catecholamines, epinephrine, and norepinephrine.
-
D-Gulonic acid γ-lac...
L-Gulonolactone (also known as reduced ascorbic acid RAA) is the substrate of the enzyme L-gulono-14-lactone oxidoreductase (EC 1.1.3.8) which catalyzes the last step of the biosynthesis of L-ascorbic acid (vitamin C) in plants and animals.
-
P-XSC
P-XSC has anticancer activity, inhibits proliferation of colonic epithelial cells in patients with adenomatous polyps, and may be used in the study of breast cancer.
Cart
sales@molnova.com